| SIU Medicine

Profiles

Murad Baba, MD

Neurocritical Care Specialist Neurology

751 N. Rutledge St. Suite 3100 Springfield, IL 62702

Profiles

Murad Baba, MD

Neurocritical Care Specialist Neurology

751 N. Rutledge St. Suite 3100 Springfield, IL 62702

News

Hascup Lab, SIUC collaboration to explore new path for Alzheimer’s therapy

A collaboration between neuroscience and engineering will explore a novel approach in reducing formation of plaques commonly found in those with Alzheimer’s. Kevin Hascup, PhD, of the Smith Alzheimer’s Center at SIU Medicine, and Chilman Bae, PhD, of Southern Illinois University Carbondale were awarded an SIU System Collaborative Grant to investigate how a cellular pathway called Piezo channels could be key in helping unlock better treatments for Alzheimer’s disease and related dementias. Piezo channels are located throughout the body and are like gates in our cells that open up when we feel

Profiles

Dawn Goldstein, LCPC

Licensed Clinical Professional Counselor Family Medicine

520 N. 4th St. Springfield, IL 62702

News

What is preeclampsia?

According to the U.S. Centers for Disease Control and Prevention (CDC), about 1 in 25 pregnancies are affected by a pregnancy complication known as preeclampsia . If left undetected and untreated, preeclampsia can lead to serious and even fatal problems for a mother and her unborn child. Keep reading to learn more. What is preeclampsia? Preeclampsia (pre-e-CLAMP-si-a) is defined as persistent high blood pressure that develops during pregnancy, usually after the 20th week of gestation. In rare instances, it can also develop after pregnancy during the postpartum period. If left untreated

News

5 common diabetes myths busted

Diabetes is a chronic health condition that affects the way the body makes energy from food. Normally, the human body produces a hormone called insulin that helps turn sugar from food into energy that the body can use or store. In people with diabetes, their bodies either don't produce enough insulin or don't use insulin properly. This can cause sugar levels in the blood to rise too high, which if left untreated can cause serious health problems over time—including heart disease, kidney disease and blindness. November is National Diabetes Month , an opportunity to learn more about this

News

5 common diabetes myths busted

Diabetes is a chronic health condition that affects the way the body makes energy from food. Normally, the human body produces a hormone called insulin that helps turn sugar from food into energy that the body can use or store. In people with diabetes, their bodies either don't produce enough insulin or don't use insulin properly. This can cause sugar levels in the blood to rise too high, which if left untreated can cause serious health problems over time—including heart disease, kidney disease and blindness. November is National Diabetes Month , an opportunity to learn more about this

News

5 common diabetes myths busted

Diabetes is a chronic health condition that affects the way the body makes energy from food. Normally, the human body produces a hormone called insulin that helps turn sugar from food into energy that the body can use or store. In people with diabetes, their bodies either don't produce enough insulin or don't use insulin properly. This can cause sugar levels in the blood to rise too high, which if left untreated can cause serious health problems over time—including heart disease, kidney disease and blindness. November is National Diabetes Month , an opportunity to learn more about this

Trial

Internal Medicine

HyPhen: Title-Hypertension Phenotype Study

Active recruiting

This is a local research study to relate heart health and various components found in your body (body fat, sodium, etc.) to high blood pressure during pregnancy, and those with apparently normal blood pressure.

Eligible participants include those with high blood pressure, those receiving treatment for their high blood pressure, women who had high blood pressure during pregnancy, and those with apparently normal blood pressure.

Trial

Internal Medicine

Mineralys (MLS-101-202): A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL ARM, MULTI-CENTER, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LORUNDROSTAT IN SUBJECTS WITH UNCONTROLLED HYPERTENSION ON A STANDARDIZED MEDICATION REGIMEN

Active recruiting

The purpose of this clinical trial is to assess the blood pressure lowering effects of lorundrostat, taken once daily, in patients with high blood pressure.

Eligible patients include those who currently have a diagnosis of high blood pressure, despite having taken or are currently taking anti-hypertensive medications.